MX2023003933A - Derivados de acetamido-feniltetrazol y métodos para utilizar los mismos. - Google Patents
Derivados de acetamido-feniltetrazol y métodos para utilizar los mismos.Info
- Publication number
- MX2023003933A MX2023003933A MX2023003933A MX2023003933A MX2023003933A MX 2023003933 A MX2023003933 A MX 2023003933A MX 2023003933 A MX2023003933 A MX 2023003933A MX 2023003933 A MX2023003933 A MX 2023003933A MX 2023003933 A MX2023003933 A MX 2023003933A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- acetamido
- same
- phenyltetrazole
- phenyltetrazole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063088788P | 2020-10-07 | 2020-10-07 | |
| PCT/US2021/053937 WO2022076663A1 (en) | 2020-10-07 | 2021-10-07 | Acetamido-phenyltetrazole derivatives and methods of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023003933A true MX2023003933A (es) | 2023-07-05 |
Family
ID=78483546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023003933A MX2023003933A (es) | 2020-10-07 | 2021-10-07 | Derivados de acetamido-feniltetrazol y métodos para utilizar los mismos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11739089B2 (enExample) |
| EP (1) | EP4225747A1 (enExample) |
| JP (2) | JP7823036B2 (enExample) |
| KR (1) | KR20230104151A (enExample) |
| CN (1) | CN116964044B (enExample) |
| AU (1) | AU2021358074A1 (enExample) |
| CA (1) | CA3194694A1 (enExample) |
| IL (1) | IL301516A (enExample) |
| MX (1) | MX2023003933A (enExample) |
| TW (1) | TWI900672B (enExample) |
| WO (1) | WO2022076663A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016057931A1 (en) | 2014-10-10 | 2016-04-14 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| CN110312130B (zh) * | 2019-06-25 | 2021-10-15 | 浙江大华技术股份有限公司 | 基于三角模式的帧间预测、视频编码方法及设备 |
| WO2022076663A1 (en) | 2020-10-07 | 2022-04-14 | Athenex, Inc. | Acetamido-phenyltetrazole derivatives and methods of using the same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5663179A (en) | 1992-07-10 | 1997-09-02 | Laboratoires Glaxo Sa | Certain isoquinoline derivatives having anti-tumor properties |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| GB9717576D0 (en) | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
| KR100557093B1 (ko) | 2003-10-07 | 2006-03-03 | 한미약품 주식회사 | 다약제 내성 저해 활성을 갖는 테트라졸 유도체 및 그의제조방법 |
| KR101466245B1 (ko) * | 2010-01-15 | 2014-12-01 | 한미사이언스 주식회사 | 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물 |
| KR101986683B1 (ko) * | 2012-12-13 | 2019-06-10 | 한미약품 주식회사 | 테트라졸 유도체를 활성 성분으로 포함하는 용해도가 개선된 고체 분산체 |
| WO2015152433A1 (en) | 2014-03-31 | 2015-10-08 | Hanmi Pharm. Co., Ltd. | Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same |
| KR102293907B1 (ko) | 2015-06-30 | 2021-08-26 | 한미약품 주식회사 | 이리노테칸 함유 경구용 고형제제 및 그 제조방법 |
| TWI715636B (zh) | 2015-09-30 | 2021-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
| TWI833710B (zh) | 2017-10-06 | 2024-03-01 | 香港商慧源香港創新有限公司 | 高單位含量口服型紫杉烷組合物及方法 |
| WO2022076663A1 (en) | 2020-10-07 | 2022-04-14 | Athenex, Inc. | Acetamido-phenyltetrazole derivatives and methods of using the same |
-
2021
- 2021-10-07 WO PCT/US2021/053937 patent/WO2022076663A1/en not_active Ceased
- 2021-10-07 MX MX2023003933A patent/MX2023003933A/es unknown
- 2021-10-07 US US17/495,935 patent/US11739089B2/en active Active
- 2021-10-07 CA CA3194694A patent/CA3194694A1/en active Pending
- 2021-10-07 IL IL301516A patent/IL301516A/en unknown
- 2021-10-07 CN CN202180079852.2A patent/CN116964044B/zh active Active
- 2021-10-07 AU AU2021358074A patent/AU2021358074A1/en active Pending
- 2021-10-07 TW TW110137339A patent/TWI900672B/zh active
- 2021-10-07 JP JP2023521299A patent/JP7823036B2/ja active Active
- 2021-10-07 KR KR1020237015140A patent/KR20230104151A/ko active Pending
- 2021-10-07 EP EP21801761.4A patent/EP4225747A1/en active Pending
-
2026
- 2026-02-18 JP JP2026024155A patent/JP2026090442A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023544615A (ja) | 2023-10-24 |
| CN116964044B (zh) | 2026-03-06 |
| KR20230104151A (ko) | 2023-07-07 |
| US11739089B2 (en) | 2023-08-29 |
| AU2021358074A1 (en) | 2023-04-27 |
| CN116964044A (zh) | 2023-10-27 |
| IL301516A (en) | 2023-05-01 |
| CA3194694A1 (en) | 2022-04-14 |
| US20220106312A1 (en) | 2022-04-07 |
| TWI900672B (zh) | 2025-10-11 |
| TW202233593A (zh) | 2022-09-01 |
| JP7823036B2 (ja) | 2026-03-03 |
| EP4225747A1 (en) | 2023-08-16 |
| JP2026090442A (ja) | 2026-06-02 |
| WO2022076663A1 (en) | 2022-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2025000642A (es) | Compuestos macrociclicos para el tratamiento de cancer | |
| JOP20210241A1 (ar) | مركبات مدمجة ثلاثية الحلقة مفيدة كعوامل مضادة للسرطان | |
| MX2022009043A (es) | Compuestos de sulfonimidamida como moduladores de nlrp3. | |
| EP4316524A3 (en) | Camptothecin derivatives | |
| EP4365179A3 (en) | Novel rapamycin derivatives | |
| TW200621762A (en) | Novel compounds | |
| ZA202400595B (en) | Spirocyclic compounds | |
| MY206712A (en) | Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication | |
| WO2021226208A3 (en) | Heteroaromatic macrocyclic ether chemotherapeutic agents | |
| MEP23808A (en) | Pyridine[3,4-b]pyrazinones | |
| MX2009003874A (es) | Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos. | |
| EA200700099A1 (ru) | Производные пиридина | |
| MX2023001445A (es) | Compuestos de piridazina 6-sustituidos como degradadores de smarca2 y/o smarca4. | |
| MX2010013682A (es) | Derivados de 2,4-diamino-l,3,5-triazina triciclicos utiles para el tratamiento del cancer y trastornos mieloproliferativos. | |
| MX2024009925A (es) | Composiciones y metodos para tratar trastornos del snc. | |
| MX2023006063A (es) | Composiciones y metodos para el tratamiento de trastornos del sistema nervioso central. | |
| NO20080670L (no) | Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister | |
| MX2023003927A (es) | Derivados de acetamido-fenilbenzamida y métodos para utilizar los mismos. | |
| MX2025000377A (es) | Preparacion de sales, esteres y conjugados estables de psilocina y usos de los mismos | |
| MX2025008428A (es) | Derivados de piperidina como inhibidores de mettl3 | |
| PH12012501237A1 (en) | (methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutic uses | |
| MX2025007158A (es) | Inhibidores de gmp?amp sintasa ciclica y sus usos | |
| MX2021003508A (es) | Derivados de 5-azaindazol como antagonistas del receptor de adenosina. | |
| MX2020013291A (es) | Derivados de piridinilo alcoxisustituido como antagonistas del receptor lpa1 y su uso en el tratamiento de la fibrosis. | |
| PH12021553178A1 (en) | Pyridin-3-yl derivatives |